EMEIS SA (EMEIS.PA) Stock Fundamental Analysis

EPA:EMEIS • FR001400NLM4

15.51 EUR
+1.2 (+8.39%)
Last: Feb 23, 2026, 10:10 AM
Fundamental Rating

2

EMEIS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 32 industry peers in the Health Care Providers & Services industry. EMEIS has a bad profitability rating. Also its financial health evaluation is rather negative. EMEIS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • EMEIS had negative earnings in the past year.
  • EMEIS had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: EMEIS reported negative net income in multiple years.
  • In the past 5 years EMEIS always reported a positive cash flow from operatings.
EMEIS.PA Yearly Net Income VS EBIT VS OCF VS FCFEMEIS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

  • EMEIS has a worse Return On Assets (-2.22%) than 87.50% of its industry peers.
  • EMEIS's Return On Equity of -18.40% is on the low side compared to the rest of the industry. EMEIS is outperformed by 84.38% of its industry peers.
  • The Return On Invested Capital of EMEIS (0.92%) is worse than 87.50% of its industry peers.
Industry RankSector Rank
ROA -2.22%
ROE -18.4%
ROIC 0.92%
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EMEIS.PA Yearly ROA, ROE, ROICEMEIS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200 250

1.3 Margins

  • EMEIS's Operating Margin of 2.41% is on the low side compared to the rest of the industry. EMEIS is outperformed by 75.00% of its industry peers.
  • In the last couple of years the Operating Margin of EMEIS has declined.
  • The Profit Margin and Gross Margin are not available for EMEIS so they could not be analyzed.
Industry RankSector Rank
OM 2.41%
PM (TTM) N/A
GM N/A
OM growth 3Y-79.7%
OM growth 5Y-64.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMEIS.PA Yearly Profit, Operating, Gross MarginsEMEIS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EMEIS is destroying value.
  • Compared to 1 year ago, EMEIS has more shares outstanding
  • Compared to 5 years ago, EMEIS has less shares outstanding
  • EMEIS has a worse debt/assets ratio than last year.
EMEIS.PA Yearly Shares OutstandingEMEIS.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
EMEIS.PA Yearly Total Debt VS Total AssetsEMEIS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 0.66, we must say that EMEIS is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of EMEIS (0.66) is worse than 68.75% of its industry peers.
  • EMEIS has a debt to FCF ratio of 22.97. This is a negative value and a sign of low solvency as EMEIS would need 22.97 years to pay back of all of its debts.
  • The Debt to FCF ratio of EMEIS (22.97) is worse than 71.88% of its industry peers.
  • A Debt/Equity ratio of 4.67 is on the high side and indicates that EMEIS has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 4.67, EMEIS is doing worse than 78.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.67
Debt/FCF 22.97
Altman-Z 0.66
ROIC/WACC0.18
WACC4.97%
EMEIS.PA Yearly LT Debt VS Equity VS FCFEMEIS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

  • EMEIS has a Current Ratio of 0.59. This is a bad value and indicates that EMEIS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EMEIS has a worse Current ratio (0.59) than 75.00% of its industry peers.
  • A Quick Ratio of 0.58 indicates that EMEIS may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.58, EMEIS perfoms like the industry average, outperforming 40.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.58
EMEIS.PA Yearly Current Assets VS Current LiabilitesEMEIS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

  • The earnings per share for EMEIS have decreased strongly by -136.38% in the last year.
  • Looking at the last year, EMEIS shows a small growth in Revenue. The Revenue has grown by 6.30% in the last year.
  • Measured over the past years, EMEIS shows a quite strong growth in Revenue. The Revenue has been growing by 8.55% on average per year.
EPS 1Y (TTM)-136.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.16%
Revenue 1Y (TTM)6.3%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%4.92%

3.2 Future

  • The Earnings Per Share is expected to grow by 24.84% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 2.70% on average over the next years.
EPS Next Y34.85%
EPS Next 2Y25.2%
EPS Next 3Y24.49%
EPS Next 5Y24.84%
Revenue Next Year5.58%
Revenue Next 2Y4.44%
Revenue Next 3Y4.41%
Revenue Next 5Y2.7%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EMEIS.PA Yearly Revenue VS EstimatesEMEIS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
EMEIS.PA Yearly EPS VS EstimatesEMEIS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 100 -100 200

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EMEIS. In the last year negative earnings were reported.
  • Also next year EMEIS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EMEIS.PA Price Earnings VS Forward Price EarningsEMEIS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EMEIS is valued more expensive than 81.25% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, EMEIS is valued a bit cheaper than the industry average as 78.13% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.17
EV/EBITDA 16.65
EMEIS.PA Per share dataEMEIS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • A more expensive valuation may be justified as EMEIS's earnings are expected to grow with 24.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.2%
EPS Next 3Y24.49%

0

5. Dividend

5.1 Amount

  • No dividends for EMEIS!.
Industry RankSector Rank
Dividend Yield 0%

EMEIS SA

EPA:EMEIS (2/23/2026, 10:10:06 AM)

15.51

+1.2 (+8.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-28
Earnings (Next)02-17
Inst Owners58.81%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap2.50B
Revenue(TTM)5.77B
Net Income(TTM)-292.00M
Analysts46.67
Price Target13.97 (-9.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)9.23%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.43
P/FCF 7.17
P/OCF 4.17
P/B 1.58
P/tB N/A
EV/EBITDA 16.65
EPS(TTM)-1.79
EYN/A
EPS(NY)-0.97
Fwd EYN/A
FCF(TTM)2.16
FCFY13.94%
OCF(TTM)3.72
OCFY23.96%
SpS35.75
BVpS9.83
TBVpS-7.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.22%
ROE -18.4%
ROCE 1.33%
ROIC 0.92%
ROICexc 0.92%
ROICexgc 1.22%
OM 2.41%
PM (TTM) N/A
GM N/A
FCFM 6.05%
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-77.67%
ROICexgc growth 5Y-61.93%
ROICexc growth 3Y-76.54%
ROICexc growth 5Y-61.39%
OM growth 3Y-79.7%
OM growth 5Y-64.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 4.67
Debt/FCF 22.97
Debt/EBITDA 12.84
Cap/Depr 57.31%
Cap/Sales 4.35%
Interest Coverage 250
Cash Conversion 103.99%
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.58
Altman-Z 0.66
F-Score5
WACC4.97%
ROIC/WACC0.18
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)5.82%
Cap/Sales(5y)13.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.16%
EPS Next Y34.85%
EPS Next 2Y25.2%
EPS Next 3Y24.49%
EPS Next 5Y24.84%
Revenue 1Y (TTM)6.3%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%4.92%
Revenue Next Year5.58%
Revenue Next 2Y4.44%
Revenue Next 3Y4.41%
Revenue Next 5Y2.7%
EBIT growth 1Y228.74%
EBIT growth 3Y-77.78%
EBIT growth 5Y-61.97%
EBIT Next Year10752.2%
EBIT Next 3Y414.89%
EBIT Next 5Y255.33%
FCF growth 1Y-30.07%
FCF growth 3YN/A
FCF growth 5Y14.52%
OCF growth 1Y139.57%
OCF growth 3Y-14.45%
OCF growth 5Y-10.16%

EMEIS SA / EMEIS.PA FAQ

What is the ChartMill fundamental rating of EMEIS SA (EMEIS.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to EMEIS.PA.


What is the valuation status of EMEIS SA (EMEIS.PA) stock?

ChartMill assigns a valuation rating of 2 / 10 to EMEIS SA (EMEIS.PA). This can be considered as Overvalued.


Can you provide the profitability details for EMEIS SA?

EMEIS SA (EMEIS.PA) has a profitability rating of 1 / 10.


What is the financial health of EMEIS SA (EMEIS.PA) stock?

The financial health rating of EMEIS SA (EMEIS.PA) is 1 / 10.


How sustainable is the dividend of EMEIS SA (EMEIS.PA) stock?

The dividend rating of EMEIS SA (EMEIS.PA) is 0 / 10 and the dividend payout ratio is 0%.